Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 298.30M P/E - EPS this Y 21.70% Ern Qtrly Grth -
Income -88.38M Forward P/E -1.66 EPS next Y 29.40% 50D Avg Chg -19.00%
Sales 13.81M PEG -0.03 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 1.73 EPS next 5Y 21.22% 52W High Chg -47.00%
Recommedations 2.70 Quick Ratio 3.17 Shares Outstanding 96.21M 52W Low Chg 37.00%
Insider Own - ROA -34.89% Shares Float 48.61M Beta 0.88
Inst Own 17.75% ROE -72.64% Shares Shorted/Prior 298.51K/293.69K Price 1.48
Gross Margin 100.00% Profit Margin - Avg. Volume 240,648 Target Price 5.33
Oper. Margin -2,914.90% Earnings Date Jul 30 Volume 450,974 Change -8.07%
About DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

DBV Technologies S.A. News
11/11/24 DBV Technologies Announces Plan to Implement ADS Ratio Change
11/07/24 DBV Technologies’ stock slides as financial woes worsens
11/06/24 DBV Technologies Reports Third Quarter 2024 Financial Results
10/24/24 DBV Technologies price target raised to $7 from $5 at H.C. Wainwright
10/22/24 DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
10/18/24 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
10/14/24 Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
03:30 PM DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
09/04/24 DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/02/24 Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
07/30/24 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
07/30/24 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
07/29/24 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
07/08/24 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
06/05/24 DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
06/04/24 Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
05/30/24 DBV Technologies to Participate in Upcoming EAACI 2024 Congress
05/16/24 DBV Technologies Announces Results of its 2024 Combined General Meeting
05/09/24 DBV Technologies to Participate in Upcoming Investor Conferences
05/07/24 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBVT Chatroom

User Image Billianas Posted - 5 days ago

$DBVT Out, small position. Trend is changing here… Expecting it to drop around 0.35$ before a possible run… 1$ will be a big resistance

User Image PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of DBV Technologies. Is that bullish or bearish? $DBVT #RsiOversold #NASDAQ

User Image Miorymatulie Posted - 1 week ago

$DBVT $RAPTOR.X 🚨💥🚀🔥 PR is incoming. $BOLT.CN $.31 (+19.23%) average volume increased ~100%. I'm going to add on Monday if it's still this low. Latest News 🚀🤑 Market cap at $5.7M; Whiting’s influence may drive upward movement if new partnerships or exploration progress 1️⃣ Bolt Metals ($BOLT.CN) advances with two key updates: Ben Whiting joins as Technical Advisor, and a C$544,500 private placement closed 💸. 2️⃣ Funding: The placement includes shares and warrants, exercisable at C$0.75 for two years, with proceeds for exploration, working capital, and copper project growth ⚒️

User Image kriks2611 Posted - 1 week ago

$DBVT https://dbv-technologies.com/press_releases/dbv-technologies-announces-plan-to-implement-ads-ratio-change-3/

User Image APEDM Posted - 1 week ago

$DBVT How many people fell into the trap on October 23? Too insidious!

User Image APEDM Posted - 2 weeks ago

$DBVT There is a high chance that the FDA will refuse and xolair is better. massive loss of cash, HC Wainwright & Co/Kepler Capital recommended to buy. APEDM target price 0.4.

User Image APEDM Posted - 2 weeks ago

$DBVT https://www.yahoo.com/finance/news/dbv-technologies-stock-slides-financial-170728313.html

User Image APEDM Posted - 2 weeks ago

$DBVT The Company has incurred operating losses and negative cash flows from operations since inception. As of the date of the filling, DBV's available cash and cash equivalents will not be sufficient to support our operating plan for at least the next 12 months. As such, there is substantial doubt regarding its ability to continue as a going concern.

User Image APEDM Posted - 2 weeks ago

$DBVT peanut scam

User Image kriks2611 Posted - 2 weeks ago

$DBVT https://dbv-technologies.com/press_releases/dbv-technologies-reports-third-quarter-2024-financial-results/

User Image Mortimer2020 Posted - 2 weeks ago

$DBVT must raise more $... Clock ticking

User Image BadDice Posted - 10/31/24

$DBVT I’m outta this poc. Laters

User Image APEDM Posted - 10/28/24

$DBVT scum

User Image delrey76 Posted - 10/28/24

$DBVT

User Image Billianas Posted - 10/25/24

$DBVT sooner or later, it’s going to break 1.50$ level, target is 2$+ midterm. Had big gains here and back in.

User Image theflynews Posted - 10/25/24

Biotech Alert: Searches spiking for these stocks today - $DBVT - https://thefly.com/permalinks/entry.php/DBVTid4005804

User Image Leechanglyul Posted - 10/24/24

$DBVT Good good

User Image APEDM Posted - 10/24/24

$DBVT Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)

User Image APEDM Posted - 10/24/24

$DBVT Be aware of risks and don’t get carried away

User Image APEDM Posted - 10/24/24

$DBVT Be careful when bulls and HC are around!

User Image delrey76 Posted - 10/24/24

$DBVT

User Image ChristmasYime Posted - 10/24/24

$DBVT $1 EOD

User Image topstockalerts Posted - 10/24/24

$DBVT make or break level.. 🚨

User Image bobbydoles Posted - 10/24/24

$DBVT waiting on that $drug $mnpr type move here

User Image GirlsGoneGyno Posted - 10/24/24

$DBVT All these negative commenters, tell me you're short without telling me you a bitch ass midget. Loaded up in the $0.60's yesterday!

User Image Stocksrunner Posted - 10/24/24

🔥 Huge Day for Top Gainers! 🔥 Check out these stocks that skyrocketed today: $NXU $DBVT $QS $VEEE $MOH 🚀📈 Keep an eye on these movers!

User Image Kylian7 Posted - 10/24/24

$DBVT 1$ the smell of blood... she will quickly be drawn to this course to become compliant with Nasdaq.

User Image thetoptrader619 Posted - 10/24/24

$DBVT 33 percent so far. Beast. Follow me for more alerts

User Image APEDM Posted - 10/24/24

$DBVT H.C. Wainwright raised the firm’s price target on DBV Technologies (DBVT) to $7 from $5 and keeps a Buy rating on the shares after DBV reached an agreement with the FDA regarding the regulatory pathway for the Viaskin Peanut patch in toddlers aged one to three under the Accelerated Approval pathway.

User Image topstockalerts Posted - 10/24/24

Pre Market Top Gainers PT2 $TSLL $TSLR $BOF $TVGN $DBVT

Analyst Ratings
HC Wainwright & Co. Buy Aug 1, 24
JMP Securities Market Outperform Jul 31, 24
HC Wainwright & Co. Buy May 8, 24
HC Wainwright & Co. Buy Feb 21, 24
HC Wainwright & Co. Buy Nov 13, 23
Goldman Sachs Sell Nov 2, 23
JMP Securities Market Outperform Aug 1, 23
HC Wainwright & Co. Buy Aug 1, 23
JMP Securities Market Outperform May 11, 23